Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jindong Guo"'
Autor:
Guangyu Chen, Long Yuan, Yong Zhang, Tiepeng Li, Hongqin You, Lu Han, Peng Qin, Yao Wang, Xue Liu, Jindong Guo, Mengyu Zhang, Kuang Zhang, Linlin Li, Peng Yuan, Benling Xu, Quanli Gao
Publikováno v:
Translational Oncology, Vol 50, Iss , Pp 102138- (2024)
Adoptive cell therapy (ACT) has revolutionized the treatment of patients with cancer. The success of ACT depends largely on transferred T cell status, particularly their less-differentiated state with stem cell-like properties, which enhances ACT eff
Externí odkaz:
https://doaj.org/article/a89a39a3ed584614b63bb09c2d60f1c4
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 47, Iss , Pp 100787- (2024)
Background: We aimed to assess the value of stereotactic body radiotherapy (SBRT) delivered under the situation of controlled or progressed disease during ICI therapy in advanced or recurrent NSCLC. Methods: We retrospectively collected patients with
Externí odkaz:
https://doaj.org/article/edc26727e5c34c8b9367b9e756e77d06
Autor:
Baozhen Ma, Yu Zhou, Yiman Shang, Yong Zhang, Benling Xu, Xiaomin Fu, Jindong Guo, Yonghao Yang, Fang Zhang, Mengyuan Zhou, Hao Huang, Fanghui Li, Hongwei Lin, Lingdi Zhao, Zibing Wang, Quanli Gao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Despite recent progress in treating advanced non-small cell lung cancer, clinical intervention in extensive-stage small-cell lung cancer (ES-SCLC) remains stagnant. The purpose of this study was to evaluate the clinical efficacy of cytokine-induced k
Externí odkaz:
https://doaj.org/article/fa0f124aa8244db3847402348736cf72
Publikováno v:
Dentistry Journal, Vol 11, Iss 2, p 54 (2023)
Inflammation is a crucial step prior to healing, and the regulatory effects of endodontic materials on the immune response can influence tissue repair. This review aimed to answer whether endodontic sealers can modulate the immune cells and inflammat
Externí odkaz:
https://doaj.org/article/b2856f6c5e594e3fafa7d5e30ef0103b
Autor:
Lingdi Zhao, Tiepeng Li, Yongping Song, Yonghao Yang, Baozhen Ma, Yong Zhang, Yiman Shang, Benling Xu, Jindong Guo, Peng Qin, Lu Han, Xiaomin Fu, Hongwei Lin, Liang Liu, Xiubao Ren, Zibing Wang, Quanli Gao
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Background and ObjectiveThe results of the CheckMate 025 trial established the status of nivolumab in the second-line treatment of metastatic renal cell carcinoma (mRCC), with an objective response rate (ORR) of 25% and a complete response (CR) rate
Externí odkaz:
https://doaj.org/article/243413ee34b54048850fc83d50d4b9e3
Autor:
Jindong Guo, Haibin Yuan, Yimin Zhu, Zhiyuan Che, Bei Zhang, Ding Zhang, Ying Zhou, Liwen Xiong
Publikováno v:
Medicine; 2/23/2024, Vol. 103 Issue 8, p1-6, 6p
Autor:
Quanli Gao, Shengdian Wang, Hongle Li, Zhichao Tian, Zhiyong Liu, Yan Ma, Chaojie Feng, Dongfeng Yuan, Kai Zhang, Qingjun Li, Yiman Shang, Fang Zhang, Baozhen Ma, Benling Xu, Peng Qin, Guangyu Chen, Jindong Guo, Yong Zhang, Yao Wang, Yonghao Yang, Lingdi Zhao, Tiepeng Li
Information on previous treatment of patients included in the observational study.LTIL-01.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127374600f3bc19ced36ce064906df92
https://doi.org/10.1158/0008-5472.22430001.v1
https://doi.org/10.1158/0008-5472.22430001.v1
Autor:
Quanli Gao, Shengdian Wang, Hongle Li, Zhichao Tian, Zhiyong Liu, Yan Ma, Chaojie Feng, Dongfeng Yuan, Kai Zhang, Qingjun Li, Yiman Shang, Fang Zhang, Baozhen Ma, Benling Xu, Peng Qin, Guangyu Chen, Jindong Guo, Yong Zhang, Yao Wang, Yonghao Yang, Lingdi Zhao, Tiepeng Li
Additional information on patients included in Figure 1-5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21544703108da0ea0bec1bd1741aa7a4
https://doi.org/10.1158/0008-5472.22429974.v1
https://doi.org/10.1158/0008-5472.22429974.v1
Autor:
Quanli Gao, Shengdian Wang, Hongle Li, Zhichao Tian, Zhiyong Liu, Yan Ma, Chaojie Feng, Dongfeng Yuan, Kai Zhang, Qingjun Li, Yiman Shang, Fang Zhang, Baozhen Ma, Benling Xu, Peng Qin, Guangyu Chen, Jindong Guo, Yong Zhang, Yao Wang, Yonghao Yang, Lingdi Zhao, Tiepeng Li
Both tumor-infiltrating lymphocytes (TIL) and PD-1+ peripheral blood lymphocytes (PBL) are enriched for tumor-reactive clones recognizing known and unknown tumor antigens. However, the relationship between the T-cell receptor-β (TCRβ) repertoires o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de1a5429ca181b7c6c3355d612947af
https://doi.org/10.1158/0008-5472.c.6513504
https://doi.org/10.1158/0008-5472.c.6513504
Publikováno v:
Journal of leukocyte biologyREFERENCES. 112(6)
Human γδ T cells hold a pivotal role in tumor immunosurveillance through their prompt activation and cytokine secretion and have received much attention in adoptive immunotherapy of clear cell renal cell carcinoma (ccRCC). However, the therapeutic